Ajax Therapeutics

About:

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

Website: https://www.ajaxtherapeutics.com/

Top Investors: Schrödinger, RA Capital Management, Point72 Ventures, NYU Langone Health, EcoR1 Capital

Description:

Ajax Therapeutics is an NYC-based biotechnology company applying computational chemistry and structure-based technologies to develop novel small molecules for hematologic malignancies

Total Funding Amount:

$143M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)ajaxtherapeutics.com

Founders:

Martin Vogelbaum

Number of Employees:

1-10

Last Funding Date:

2024-05-13

IPO Status:

Private

Industries: